On June 3, 2025, Phathom Pharmaceuticals held their Annual Meeting where stockholders voted on various proposals including the election of directors, approval of executive compensation, and the frequency of future votes on this compensation; notable votes included 34 million for director Heidi Kunz and a ratification of Ernst & Young as auditors with over 51 million in favor.